Monoamine uptake inhibitors block α7-nAChR-mediated cerebral nitrergic neurogenic vasodilation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 1, 2006, Pages

  Long, Cheng ^a   Chen, Mei Fang ^b   Sarwinski, Susan J ^a   Chen, Po Yi ^b   Si, Minliang ^a   Hoffer, Barry J ^c   Evans, M Steven ^a   Lee, Tony J F ^a,b,d  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Desipramine; Imipramine; In vitro tissue bath; Porcine basilar artery

Indexed keywords

BUNGAROTOXIN RECEPTOR; CHOLINERGIC RECEPTOR; DESIPRAMINE; MONOAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MYOGRAPHY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; SUPERIOR CERVICAL GANGLION; VASODILATATION; XENOPUS;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BASILAR ARTERY; BIOGENIC MONOAMINES; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; DESIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMIPRAMINE; MALE; METABOLIC CLEARANCE RATE; NEURONS; NITRIC OXIDE; OOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SUPERIOR CERVICAL GANGLION; SWINE; VASODILATION; XENOPUS LAEVIS;

EID: 33745698654     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01192.2005     Document Type: Article

References (28)

1. Albuquerque EX, Alkondon M, Pereira EFR, Castro NG, Schrattenholz A, Barbosa CTF, Bonfante-Cabarcas R, Aracava Y, Eisenberg HM, and Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280: 1117-1136, 1997.
2. Alkondon M, Reinhardt S, Lobron C, Hermsen B, Maelicke A, and Albuquerque EX. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. II. The rundown and inward rectification of agonist-elicited whole-cell currents and identification of receptor subunits by in situ hybridization studies. J Pharmacol Exp Ther 271: 494-506, 1994.
3. Alkondon M, Pereira EF, Cortes WS, Maelicke A, and Albuquerque EX. Choline is a selective agonist of α7-nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 9: 2734-2742, 1997.
4. Besret L, Debruyne D, Rioux P, Bonvalot T, Moulin M, Zarifian E, and Baron JC. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat. J Pharm Sci 85: 291-295, 1996.
5. 2+. J Pharmacol Exp Ther 277: 432-444, 1996.
6. Clarke EGC. Analytical and toxicological data: monographs. In: Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluid, and Post-Mortem Material, edited by Moffat AC, Jackson JV, Moss MS, and Widdop B. London: Pharmaceutical Press, 1986.
7. Fryer JD and Lukas RJ. Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function. J Neurochem 72: 1117-1124, 1999.
8. Genzen JR, Van Cleve W, and McGehee DS. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J Neurophysiol 86: 1773-1782, 2001.
9. Gumilar F, Arias HR, Spitzmaul G, and Bouzat C. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants. Neuropharmacology 45: 964-976, 2003.
10. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100, 1981.
11. Hennings ECP, Kiss JP, De Oliveira K, Toth PT, and Vizi ES. Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices. J Neurochem 73: 1043-1050, 1999.
12. Hoehn-Saric R, Schlaepfer TE, Greenberg BD, McLeod DR, Pearlson GD, and Wong SH. Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Res 108: 89-100, 2001.
13. Izaguirre V, Fernandez-Fernandez JM, Cena V, and Gonzalez-Garcia C. Tricyclic antidepressants block cholinergic nicotinic receptors and ATP secretion in bovine chromaffin cells. FEBS Lett 418: 39-42, 1997.
14. Lee TJF, Zhang W, and Sarwinski S. Presynaptic β2-adrenoceptors mediate nicotine-induced NOergic dilation in porcine basilar arteries. Am J Physiol Heart Circ Physiol 279: H808-H816, 2000.
15. 2+ channels in cultured rat sphenopalatine ganglion neurons: an immunohistochemical and electrophysiological study. J Cereb Blood Flow Metab 20: 183-191, 2000.
16. Long C, Si M, Sarwinski S, Chen M, Evans M, and Lee TJF. Imipramine, desipramine and fluoxetine inhibit choline-induced α7-neuronal nicotinic acetylcholine receptor-mediated cerebral nitrergic vasodilation (Abstract). 33rd Annu Meeting Soc Neurosci New Orleans 2003.
17. Lopez-Valdes HE and Garcia-Colunga J. Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake. Mol Psychiatry 6: 511-519, 2001.
18. Maggi L, Palma E, Miledi R, and Eusebi F. Effects of fluoxetine on wild and mutant neuronal α7 nicotinic receptors. Mol Psychiatry 3: 350-355, 1998.
19. Mongeau R, Blier P, and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 23: 145-195, 1997.
20. Nobler MS, Olvet KR, and Sackeim HA. Effects of medications on cerebral blood flow in late-life depression. Curr Psychiatry Rep 4: 51-58, 2002.
21. Papke RL, Bencheriff M, and Lippiello P. An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7-subtype. Neurosci Lett 213: 201-204, 1996.
22. Passero S, Nardini M, and Battistini N. Regional cerebral blood flow changes following chronic administration of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatry 19: 627-636, 1995.
23. Shytle RD, Silver AA, Lukas RJ, Newman MB, Sheehan DV, and Sanberg PR. Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry 7: 525-535, 2002.
24. 2+ inhibition of sympathetic α7-nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilation in porcine basilar arteries. J Pharmacol Exp Ther 305: 1124-1131, 2003.
25. Si ML and Lee TJF. α7-Nicotinic acetylcholine receptors on cerebral perivascular sympathetic nerves mediate choline-induced nitrergic neurogenic vasodilation. Circ Res 91: 62-69, 2002.
26. Si ML and Lee TJF. Presynaptic α7-nicotinic acetylcholine receptors mediate nicotine-induced nitric oxidergic neurogenic vasodilation in porcine basilar arteries. J Pharmacol Exp Ther 298: 122-128, 2001.
27. Yu JG and Lee TJF. 5-Hydroxytryptamine-containing fibers in cerebral arteries of the cat, rat and guinea pig. Blood Vessels 26: 33-43, 1989.
28. Zhang W, Edvinsson L, and Lee TJF. Mechanism of nicotine-induced neurogenic vasodilation in the porcine basilar artery. J Pharmacol Exp Ther 284: 790-797, 1998.